Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Nov 3;17(11):e0272828. doi: 10.1371/journal.pone.0272828

Endometriosis and pregnancy: The illusion of recovery

Axel Veyrié 1,#, Antoine Netter 1,2,*,#, Xavier Carcopino 1,2, Laura Miquel 1, Aubert Agostini 1, Blandine Courbiere 1,2
Editor: Diego Raimondo3
PMCID: PMC9632839  PMID: 36327260

Abstract

The objective of this study was to investigate the feelings and experiences of infertile women with deep infiltrating endometriosis during and after a first pregnancy achieved by in-vitro fertilization (IVF). We conducted a qualitative monocentric study between May and November 2020. Semi-structured interviews were undertaken with infertile women with deep infiltrating endometriosis who achieved a first pregnancy by IVF and delivered at least two years prior to the interview. Data analysis was performed using an inductive approach to identify recurrent categories and themes. Fifteen interviews were conducted to reach data saturation. Pregnancy appeared to improve all components of the experience of endometriosis that were explored (psychological and physical well-being, social relationships, professional life, and sexuality). This improvement was only temporary and all symptoms and negative aspects of the women’s quality of life reappeared after a variable period.

1. Introduction

Although endometriosis affects approximately 10% of women of childbearing age, its natural history is still debated [1, 2]. It is commonly accepted that endometriosis is a disease that progresses inconsistently and slowly [3, 4]. Recent studies, in particular imaging studies, suggest that continuous amenorrhea induced by hormonal treatments can limit the progression of deep endometriosis [5]. This also appears to be verified for amenorrhea due to pregnancy [58]. The underlying pathophysiological mechanisms are not entirely clear, but could involve the hormonal environment, in particular the increase in progesterone levels leading to luteal transformation, decidualization, and atrophy of the ectopic endometrium [9]. The interruption of retrograde menstruation has also been suggested as a pathophysiological explanation [10, 11]. The supposedly positive impact of pregnancy on endometriosis lesions has led health professionals to recommend pregnancy as a treatment for endometriosis for almost a century [12, 13]. Paradoxically, there is little research investigating the evolution of painful symptoms during and after pregnancy [13]. In 2018, Alberico et al. conducted a retrospective study involving 131 women with endometriosis. The authors found that while the women were indeed symptom-free during and immediately after delivery, 84% had a recurrence of moderate or severe pain symptomatology two years after delivery [14]. These quantitative data, although modest, appear to contradict the age-old myth of pregnancy as a treatment for endometriosis. Nevertheless, there are various reasons to suggest that pregnancy remains a uniquely special period for women with endometriosis: first, because of the difficulty in achieving pregnancy, since endometriosis is often associated with infertility; second, because of the lull in the painful symptoms; and finally, because of the complications of pregnancy, which are more frequent in women with endometriosis [15].

The objective of this study was to investigate the feelings and experiences of infertile women with deep infiltrating endometriosis during and after a first pregnancy obtained by in-vitro fertilization (IVF).

2. Method

We conducted a single-center qualitative study between May and November 2020 at the assisted-reproduction center of La Conception Hospital (Marseille, France). The study had previously received approval from the ethics committee of the University of Aix-Marseille (2020-07-05-07). All participants gave written consent after having been thoroughly informed orally and in writing about the terms of the study.

The inclusion criteria were: age between 18 and 43 years; deep infiltrating endometriosis suspected on pelvic magnetic resonance imaging (MRI) or diagnosed surgically (stages III and IV of the revised American Society for Reproductive Medicine (rASRM) classification [16]); IVF management with achievement of a first pregnancy and birth of a child who is still alive and healthy; and presence of at least one symptom immediately before IVF (dysmenorrhea, dyspareunia, or chronic pelvic pain). Exclusion criteria were: delivery less than two years or more than 10 years before the start of the study; no follow-up for more than one year in our center; poor understanding of French; or refusal to participate in the study.

Individual, in-depth, semi-structured interviews were conducted in person, by telephone, or by videoconference by a single investigator (A.V.). Signed consent was requested from participants before the interview began. The expected duration of the interviews announced to the participants was 30 minutes to one hour. A semi-structured interview guide composed of open-ended questions concerning the experience of endometriosis during IVF treatment, during pregnancy, and after delivery enabled the investigator to conduct each conversation in a semi-structured manner. Each interview was recorded and immediately transcribed verbatim, removing any information that might identify the participant. The recording was then deleted.

The data collected was coded by conducting a micro-analysis of each interview and was analyzed using an inductive approach based on a thematic analysis specific to qualitative research methodology. The coding data were compared and analyzed throughout the study in order to enrich the interview guide as needed. The study was stopped when no new data emerged during two consecutive interviews (indicating that data saturation had been achieved). The codes were then grouped and organized to create categories, which were then grouped into themes.

3. Results

Data saturation was achieved after 15 interviews. The women who agreed to participate were on average 37 ± 5 years of age at the time of the interview and had given birth on average 6 ± 2 years earlier (Table 1). Of these women, 13 of 15 had had laparoscopic endometriosis surgery before pregnancy. All patients had at least one painful symptom (dysmenorrhea, dyspareunia, or chronic pelvic pain) immediately before pregnancy. Two interviews were conducted in person, one by videoconference, and 12 by telephone. The results of the interviews are presented in three sections: 1) endometriosis and IVF management; 2) disappearance of symptoms during pregnancy and immediately after pregnancy; and 3) recurrence of symptoms.

Table 1. Main characteristics of the participants.

Participants Age at delivery (years) Time between delivery and interview (years) Surgery for endometriosis before pregnancy Hospitalization during pregnancy Pathology during pregnancy Resumption of hormonal treatment less than one year after childbirth Recurrence of pain less than one year after delivery Recurrence of pain more than one year after delivery
P1 36 4 Yes No No No No Yes
P2 29 4 Yes Yes Placenta Prævia Yes No Yes
P3 25 3 Yes No No No No No
P4 36 8 Yes Yes IUGR No Yes Yes
P5 28 9 Yes Yes TPL No No No
P6 37 7 Yes No No No No Yes
P7 33 6 Yes No Placenta Prævia + IUGR Yes Yes Yes
P8 38 7 Yes Yes Placenta Prævia Yes No Yes
P9 33 5 Yes Yes Gestational diabetes No No Yes
P10 28 7 Yes Yes TPL No No Yes
P11 34 4 Yes No No No No No
P12 32 7 No No No No No Yes
P13 28 7 Yes Yes IUGR No No Yes
P14 27 2 Yes No No No No Yes
P15 40 3 Yes Yes IUGR No Yes Yes

IUGR = Intrauterine growth restriction, TPL = threatened preterm labor

3.1. Experience of endometriosis during IVF management

3.1.1. Discontinuation of hormonal treatment

Invariably, discontinuation of contraception at the time of planned pregnancy was accompanied by an increase in pain. Several women described the ambivalence between the desire for pregnancy and the desire to resume hormonal treatment to combat painful symptoms. Pain was often identified as the main factor precipitating the abandonment of attempting to conceive naturally.

Participant 12: “Going back on the pill to stop the pain was my big question because there was always the desire to have a child, and at the same time you put yourself on the pillFinally the hope of getting there naturally is no longer possible.

3.1.2. IVF, endometriosis, and social and professional life

During the interviews, IVF treatment was often described as a social and professional hindrance in addition to the symptoms of endometriosis. Some women who already had to justify regular absenteeism from work because of painful symptoms described the fear of being dismissed or sidelined during their IVF course.

Participant 10: “My employer was making remarks to me, ‘still absent’, ‘ah you’re extending the time off work…’ yet it was a woman.”

Some women also reported almost complete avoidance of social situations to avoid having to justify their absence.

Participant 7: “This disease depletes the number of true friends () It is impossible to warn people that because of endometriosis you may have to cancel everything at the last minute. It’s very difficult to meet new people, I was always afraid I wouldn’t feel well, thinking ‘what am I going to say to them if I don’t feel well in the middle of a meal?’ It restricts everything.”

3.1.3. Infertility, dyspareunia, and sexual life

Many women described sexuality as a taboo subject within the couple because of dyspareunia. The pregnancy project was also often described as destabilizing for the couple’s equilibrium, with resumption and often planning of intercourse despite the pain. The women described their own anticipatory anxiety and the guilt of their partners. Conversely, at the time of the IVF treatment, the partner’s involvement in the attempt at pregnancy was experienced as an element that strengthened the couple’s cohesion.

Participant 5: “Sometimes my husband would say to me ‘I don’t come to you because I don’t know if you’re going to be okay, I’m afraid I’ll hurt you, I’m afraid I’ll be intrusive, I’m afraid you won’t feel like it anymore.’”

3.2. Experience of symptom resolution during pregnancy and immediately after pregnancy

3.2.1. Lull and hope for recovery

Invariably, the women described the period of pregnancy as a period of lull in the symptoms of endometriosis, leading to a very positive experience despite the occurrence of pregnancy complications for more than half of the participants. This lull was often interpreted as a cure. Most of the women explained this belief as having been encouraged by a health professional or by information from the Internet presenting pregnancy as a treatment for endometriosis. This feeling of healing persisted after childbirth, and the women interviewed often said that this was justification for not taking hormone treatment. In addition, still following the idea of a cure, some patients said that they had persisted for a long time in attempting to achieve a second spontaneous pregnancy when the first had required IVF.

Participant 13: “The symptoms did not return for three years; I was at peace. I had no more pain. I told myself that I was cured. It worked; it was great. I didn’t feel the effects of endometriosis anymore ()”

Participant 1: “I think after my pregnancy, looking back, I should have stayed on the pill. We had hope of having another child. I didn’t think the endometriosis would come back.

3.2.2. Social and professional normalization

Women often reported that the improvement in symptoms during and immediately after pregnancy allowed them to resume activities that promoted a normalization of social life.

Participant 13: “Yes, I took up sport. () Since high school, because of my painful and irregular periods, I avoided sports. It was the discovery that I was able to run 10 km.

In addition, the new status of pregnant woman or mother was described by the patients as an opportunity to conform to the norm. The entourage that had been distanced during the IVF process was, on the contrary, very present during the pregnancy and after the birth. Several patients also described that the period immediately after their maternity leave had been marked by new professional aspirations, either by the construction of more ambitious projects than before or by the idea of finding a professional field that was more benevolent towards their illness.

Participant 9: “After I changed jobs. I was fully honest from the day I was hired. The employer welcomed me with open arms (…). Talking about it paid off.”

3.2.3. Calmness within the couple

Consistently, patients described a marked improvement in interactions with their partners during and immediately after pregnancy. Several explanations were given: on the one hand, the disappearance of painful symptoms and, on the other hand, the feeling of having won a victory for both of them and the relief of achieving a pregnancy following the IVF procedure. On the other hand, most of the women described a decline in their sexuality, often attributed to the disappearance of spontaneity in intercourse following the infertility process.

Participant 10: “the IVF treatments destroyed certain things, the quality of sexual relations in particular, but strengthened other things in our couple.

3.3. Experience of the recurrence of symptoms

3.3.1. The resurgence of symptoms

The women consistently described that, after a period that varied in length but generally exceeded one year, their symptoms had gradually reappeared. The most frequently reported comments were regarding marked feelings of disappointment or disillusionment, which were related to the conviction that the pregnancy had allowed endometriosis to be cured definitively. The women described this period of gradual reappearance of symptoms very negatively. Several of them mentioned forgetting of the symptoms or denial of the disease during the lull period. The regret of not having resumed hormonal treatment after the pregnancy, often despite the advice of health professionals, was also expressed.

Participant 6: “You hope to have relief, but the relief for me was short-lived. You think maybe it will come back, but you forgot how bad the pain was. In fact, the pain before the pregnancy was more acceptable. When the pain became more intense again, () I even discussed a hysterectomy.

3.3.2. Social and professional disillusionment

Most of the women described a return to almost the same social situation as before the pregnancy, often with social avoidance. Some women verbalized the difficulties they had encountered in making their family and friends, who thought they were cured, understand the recurrence of painful symptoms.

Participant 2: “It’s been forgotten, clearly we don’t talk about it at all. Endometriosis is still associated with infertility, and I have had children, so for them it means that I am cured.

The women also most often described a feeling of professional limitation, with the renunciation of projects that had been developed immediately after the pregnancy. Only the few patients who specifically pursued a reorientation towards an environment sympathetic to their illness reported an improvement in their professional life.

Participant 6: “I later tried to go back to work full time but it was impossible. It definitely affected my work life.

3.3.3. Lassitude and inconsistent partner support

More than half of the women interviewed mentioned a deterioration in their relationship with their partner some time after the birth when the pain was on the rise. Often, women said that they had felt their partners’ weariness of the symptoms and sometimes their disinterest or disinvestment in their illness. Although only a few women had separated from their partners after delivery, the majority had already discussed the subject of divorce or separation.

Participant 7: “My husband has gotten used to seeing me in pain. (). He has lost all his empathy; he has become impervious to pain (). I blamed him and I still blame him but it’s human () he tells me it’s happened so many times.

Participant 1: “The suffering, the pain, the difficulty in managing relationships. My spouse can’t understand. Another couple might have gotten divorced.

4. Discussion

To our knowledge, this article represents the first qualitative study ever conducted about the feelings and experiences of infertile patients with endometriosis during and after a first pregnancy obtained by IVF. Inductive analysis of the interviews enabled us to construct a chronological scheme of the experience of the disease during this period. Our results suggest that during pregnancy and for a variable length of time after pregnancy, women have the momentary illusion of being cured of endometriosis. This illusion is explained in part by the lull in painful symptoms, but it is also maintained by the medical discourse, which frames pregnancy as a treatment for endometriosis. This cognitive phenomenon sometimes extends to forgetting or denying the disease, which, according to the women interviewed for this study, justifies the absence of resumption of hormonal treatment after childbirth, despite the advice of health professionals. After a variable length of time, the resurgence of symptoms is experienced very negatively by the women: first as a disappointment or disillusionment with the prospect of a cure, then by resignation and a renunciation of plans for a normal life.

Our study focuses on infertile women who have undergone IVF and achieved pregnancy. Some data in the literature have already established that endometriosis and endometriosis-induced infertility have a negative impact on quality of life [17, 18]. The qualitative data we present allow us to explore the changes that take place precisely when infertility treatments have worked, and patients are pregnant. Our results are indeed in favor of an improvement during the pregnancy following IVF but suggest that this improvement is only temporary. Only quantitative data based on questionnaires should clarify whether quality of life is durably improved after pregnancy, but our results do not seem to suggest this. The interviews deliberately address very little about surgical treatment, even though most of our patients had undergone surgery prior to IVF according to an integrated approach already described in the literature [19, 20]. It is likely that this integrated approach for endometriosis-associated infertility has an impact that should be explored to determine which of surgery or IVF has the greatest influence on patient experience. Several of our results also showed how these changes in patients’ experiences make it difficult to resume hormone treatment after pregnancy. Several data in the literature suggest that this treatment is important to reduce the symptoms and progression of endometriosis [5, 21]. Our study highlights the need to better inform patients of the importance of this medical treatment after childbirth even in the absence of symptoms.

In 2018, Leeners et al. conducted a systematic review of the literature regarding the effect of pregnancy on endometriosis [13]. Although the data were derived from a limited number of studies, some of which were not recent and all of which were retrospective and involved a small number of patients, it appears that the majority of lesions decrease in size during pregnancy. The authors nevertheless highlight that the evolution of endometriosis lesions is unpredictable, with progression in some women, and that very little research has been conducted on the long-term evolution after pregnancy. Millischer et al. conducted a retrospective study in 2019 involving 21 patients (67 deep endometriosis lesions) who had never undergone surgery and who had an MRI before and after pregnancy (with an interval of 20 ± 8 months between the two MRIs) [6]. The authors report a decrease in the mean volume of all lesions. Another retrospective study conducted by our team in 2019 on patients with rectal endometriosis lesions, eight of whom had a pregnancy, reported more mixed results for a longer duration between MRIs (51 ± 26 months), with regression noted for only one patient [5].

From a histological point of view, although there is a rationale for regression of endometriosis lesions during pregnancy due to decidualization of the ectopic endometrium and atrophy of the epithelium covering the lesions, the scientific literature is rather in favor of an inhomogeneous response of the lesions [13, 22]. Indeed, decidualization is an inconstant phenomenon and is initially responsible for an increase in lesion size before being associated with regression [2325]. Similarly, depending on the histological studies, atrophy, fibrosis or necrosis are inconsistently described, and some cases of cell proliferation have also been reported [2628].

Concerning the evolution of the symptomatology, the data are even more rare and appear to suggest a lull in symptoms during pregnancy [7, 11, 2931]. The best data concerning the evolution of symptoms after pregnancy are reported by a recent retrospective study by Alberico et al. involving 131 women interviewed before and two years after pregnancy [14]. The authors’ findings favor an overall improvement of symptoms during the long term, but nevertheless indicate the persistence or the reappearance of at least one symptom of moderate or severe intensity in 84% of participants. At the same time, the authors noted a modest improvement in quality of life and no improvement in sexual function.

Our study reports qualitative data that are broadly transferable to these findings and thus contribute to the current trend relativizing the impact of pregnancy on the long-term outcome of patients [12]. As the majority of the women who participated in our study reported, the myth of pregnancy as a treatment or principle of management of endometriosis still appears to be largely supported among health professionals treating endometriosis. Not only is there no data in the scientific literature to support the claim that pregnancy is a sustainable way of improving the life and health of women with endometriosis, but this false claim appears to have a negative impact. In fact, according to participants’ comments reported in our study, this assertion appears to be the source of false hope for women, resulting in a delay in resumption of hormonal treatment for endometriosis and a greatly degraded experience of the reappearance of symptoms. There is no doubt that pregnancy is an unavoidable and central issue in the care plan of patients with endometriosis. These women must be informed early on of the risk of infertility and must be supported in their pregnancy planning. We agree with Brigitte Leeners and Cynthia M. Farquhar in the notion that the decision to become pregnant should not be influenced by the positive or negative effect on the evolution of endometriosis [12].

5. Conclusion

The results of this qualitative study suggest that a first pregnancy obtained by IVF gives endometriosis patients the temporary illusion of a cure. The widespread myth that a pregnancy will lead to permanent improvement of endometriosis symptoms has deleterious consequences for women’s experiences at the time of symptom recurrence. More data are needed to understand the exact influence of pregnancy on the long-term evolution of the symptomatology.

Supporting information

S1 Dataset

(XLSX)

Data Availability

We uploaded the minimal dataset, and it is now fully available: https://doi.org/10.6084/m9.figshare.21354333.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362: 2389–2398. doi: 10.1056/NEJMcp1000274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gordts S, Koninckx P, Brosens I. Pathogenesis of deep endometriosis. Fertility and Sterility. 2017;108: 872–885.e1. doi: 10.1016/j.fertnstert.2017.08.036 [DOI] [PubMed] [Google Scholar]
  • 3.Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10: 261–275. doi: 10.1038/nrendo.2013.255 [DOI] [PubMed] [Google Scholar]
  • 4.Fedele L, Bianchi S, Zanconato G, Raffaelli R, Berlanda N. Is rectovaginal endometriosis a progressive disease? Am J Obstet Gynecol. 2004;191: 1539–1542. doi: 10.1016/j.ajog.2004.06.104 [DOI] [PubMed] [Google Scholar]
  • 5.Netter A, d’Avout-Fourdinier P, Agostini A, Chanavaz-Lacheray I, Lampika M, Farella M, et al. Progression of deep infiltrating rectosigmoid endometriotic nodules. Hum Reprod. 2019;34: 2144–2152. doi: 10.1093/humrep/dez188 [DOI] [PubMed] [Google Scholar]
  • 6.Millischer AE, Marcellin L, Santulli P, Maignien C, Bourdon M, Borghese B, et al. Magnetic resonance imaging presentation of deep infiltrating endometriosis nodules before and after pregnancy: A case series. PLoS ONE. 2019;14: e0223330. doi: 10.1371/journal.pone.0223330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Coccia ME, Rizzello F, Palagiano A, Scarselli G. The effect of the hormonal milieu of pregnancy on deep infiltrating endometriosis: serial ultrasound assessment of changes in size and pattern of deep endometriotic lesions. Eur J Obstet Gynecol Reprod Biol. 2012;160: 35–39. doi: 10.1016/j.ejogrb.2011.10.004 [DOI] [PubMed] [Google Scholar]
  • 8.Benaglia L, Somigliana E, Calzolari L, Busnelli A, Cardellicchio L, Ragni G, et al. The vanishing endometrioma: the intriguing impact of pregnancy on small endometriotic ovarian cysts. Gynecol Endocrinol. 2013;29: 863–866. doi: 10.3109/09513590.2013.813476 [DOI] [PubMed] [Google Scholar]
  • 9.Bilotas MA, Olivares CN, Ricci AG, Baston JI, Bengochea TS, Meresman GF, et al. Interplay between Endometriosis and Pregnancy in a Mouse Model. PLoS One. 2015;10: e0124900. doi: 10.1371/journal.pone.0124900 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24: 235–258. doi: 10.1016/s0889-8545(05)70302-8 [DOI] [PubMed] [Google Scholar]
  • 11.Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Malspeis S, Willett WC, et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol. 2004;104: 965–974. doi: 10.1097/01.AOG.0000142714.54857.f8 [DOI] [PubMed] [Google Scholar]
  • 12.Leeners B, Farquhar CM. Benefits of pregnancy on endometriosis: can we dispel the myths? Fertil Steril. 2019;112: 226–227. doi: 10.1016/j.fertnstert.2019.06.002 [DOI] [PubMed] [Google Scholar]
  • 13.Leeners B, Damaso F, Ochsenbein-Kölble N, Farquhar C. The effect of pregnancy on endometriosis-facts or fiction? Hum Reprod Update. 2018;24: 290–299. doi: 10.1093/humupd/dmy004 [DOI] [PubMed] [Google Scholar]
  • 14.Alberico D, Somigliana E, Bracco B, Dhouha D, Roberto A, Mosconi P, et al. Potential benefits of pregnancy on endometriosis symptoms. Eur J Obstet Gynecol Reprod Biol. 2018;230: 182–187. doi: 10.1016/j.ejogrb.2018.08.576 [DOI] [PubMed] [Google Scholar]
  • 15.Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Human Reproduction Update. 2019;25: 593–633. doi: 10.1093/humupd/dmz012 [DOI] [PubMed] [Google Scholar]
  • 16.Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67: 817–821. doi: 10.1016/s0015-0282(97)81391-x [DOI] [PubMed] [Google Scholar]
  • 17.Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS. Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynaecol. 2017;38: 317–319. doi: 10.1080/0167482X.2016.1244185 [DOI] [PubMed] [Google Scholar]
  • 18.Laganà AS, Condemi I, Retto G, Muscatello MRA, Bruno A, Zoccali RA, et al. Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2015;194: 30–33. doi: 10.1016/j.ejogrb.2015.08.015 [DOI] [PubMed] [Google Scholar]
  • 19.Ban Frangež H, Vrtacnik Bokal E, Štimpfel M, Divjak Budihna T, Gulino FA, Garzon S, et al. Reproductive outcomes after laparoscopic surgery in infertile women affected by ovarian endometriomas, with or without in vitro fertilisation: results from the SAFE (surgery and ART for endometriomas) trial. J Obstet Gynaecol. 2022;42: 1293–1300. doi: 10.1080/01443615.2021.1959536 [DOI] [PubMed] [Google Scholar]
  • 20.Šalamun V, Verdenik I, Laganà AS, Vrtačnik-Bokal E. Should we consider integrated approach for endometriosis-associated infertility as gold standard management? Rationale and results from a large cohort analysis. Arch Gynecol Obstet. 2018;297: 613–621. doi: 10.1007/s00404-017-4633-0 [DOI] [PubMed] [Google Scholar]
  • 21.Mabrouk M, Frascà C, Geraci E, Montanari G, Ferrini G, Raimondo D, et al. Combined oral contraceptive therapy in women with posterior deep infiltrating endometriosis. J Minim Invasive Gynecol. 2011;18: 470–474. doi: 10.1016/j.jmig.2011.04.008 [DOI] [PubMed] [Google Scholar]
  • 22.Leone Roberti Maggiore U, Ferrero S, Mangili G, Bergamini A, Inversetti A, Giorgione V, et al. A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update. 2016;22: 70–103. doi: 10.1093/humupd/dmv045 [DOI] [PubMed] [Google Scholar]
  • 23.Moen MH, Muus KM. Endometriosis in pregnant and non-pregnant women at tubal sterilization. Hum Reprod. 1991;6: 699–702. doi: 10.1093/oxfordjournals.humrep.a137411 [DOI] [PubMed] [Google Scholar]
  • 24.Ueda Y, Enomoto T, Miyatake T, Fujita M, Yamamoto R, Kanagawa T, et al. A retrospective analysis of ovarian endometriosis during pregnancy. Fertil Steril. 2010;94: 78–84. doi: 10.1016/j.fertnstert.2009.02.092 [DOI] [PubMed] [Google Scholar]
  • 25.Pateman K, Moro F, Mavrelos D, Foo X, Hoo W-L, Jurkovic D. Natural history of ovarian endometrioma in pregnancy. BMC Women’s Health. 2014;14: 128. doi: 10.1186/1472-6874-14-128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Cohen J, Naoura I, Castela M, Von N’Guyen T, Oster M, Fontaine R, et al. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis. Eur J Obstet Gynecol Reprod Biol. 2014;183: 70–77. doi: 10.1016/j.ejogrb.2014.10.038 [DOI] [PubMed] [Google Scholar]
  • 27.Razzi S, Rubegni P, Sartini A, De Simone S, Fava A, Cobellis L, et al. Umbilical endometriosis in pregnancy: a case report. Gynecol Endocrinol. 2004;18: 114–116. doi: 10.1080/09513590310001653008 [DOI] [PubMed] [Google Scholar]
  • 28.Pisanu A, Deplano D, Angioni S, Ambu R, Uccheddu A. Rectal perforation from endometriosis in pregnancy: Case report and literature review. World J Gastroenterol. 2010;16: 648–651. doi: 10.3748/wjg.v16.i5.648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Koga K, Takemura Y, Osuga Y, Yoshino O, Hirota Y, Hirata T, et al. Recurrence of ovarian endometrioma after laparoscopic excision. Hum Reprod. 2006;21: 2171–2174. doi: 10.1093/humrep/del125 [DOI] [PubMed] [Google Scholar]
  • 30.Barbieri M, Somigliana E, Oneda S, Ossola MW, Acaia B, Fedele L. Decidualized ovarian endometriosis in pregnancy: a challenging diagnostic entity. Hum Reprod. 2009;24: 1818–1824. doi: 10.1093/humrep/dep089 [DOI] [PubMed] [Google Scholar]
  • 31.Porpora MG, Pallante D, Ferro A, Crisafi B, Bellati F, Benedetti Panici P. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil Steril. 2010;93: 716–721. doi: 10.1016/j.fertnstert.2008.10.018 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Diego Raimondo

14 Oct 2022

PONE-D-22-21031Endometriosis and pregnancy: the illusion of recovery.PLOS ONE

Dear Dr. Netter,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Diego Raimondo

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I read with great interest the manuscript, which falls within the aim of this Journal. In my honest opinion, the topic is interesting enough to attract the readers’ attention. Nevertheless, the authors should clarify some points and improve the discussion, as suggested below.

Authors should consider the following recommendations:

- Manuscript should be further revised in order to correct some typos and improve style.

- I would suggest to discuss, at least briefly, the results from the SAFE (surgery and ART for endometriomas) trial, and in general of the integrated approach (surgery + ART) aimed to improve reproductive outcomes in women with endometriosis-associated infertility (PMID: 34585638; PMID: 29274003).

- Authors should discuss the detrimental role of infertility associated with endometriosis on psychological wellbeing (they may refer to: PMID: 27750472; PMID: 26319653).

Reviewer #2: thank you to give me tha chence to revie this qualitative study on the illusion of recovery during pregnancy involving patients affected by endometriosis. The study is well conducted and explored a very important topic giving new insights to medical literature. It can help counselling patients in our outpatient clinics.

I suggest only to revise english language throughout the manuscript and add relevant and specific literature regarding the medical therapy adopted to treat deep lesions (doi 10.1016/j.jmig.2011.04.008) focusing on the importance to suggest medical therapy also after delivery.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Nov 3;17(11):e0272828. doi: 10.1371/journal.pone.0272828.r002

Author response to Decision Letter 0


19 Oct 2022

Reviewer #1: I read with great interest the manuscript, which falls within the aim of this Journal. In my honest opinion, the topic is interesting enough to attract the readers’ attention. Nevertheless, the authors should clarify some points and improve the discussion, as suggested below.

Response: We thank reviewer #1 for his/her comments.

Authors should consider the following recommendations:

- Manuscript should be further revised in order to correct some typos and improve style.

Response: The reviewer is right, there was a need to review the English. We did a full proofreading and editing throughout the manuscript to improve the style and syntax. We also commissioned scribbr to validate this proofreading (https://www.scribbr.fr/). We enclose the invoice as an additional document as proof. We hope the result will be satisfactory. Nevertheless, we know that these proofreading companies are not foolproof. If the reviewer finds any errors that have escaped our attention, we will gladly correct them.

- I would suggest to discuss, at least briefly, the results from the SAFE (surgery and ART for endometriomas) trial, and in general of the integrated approach (surgery + ART) aimed to improve reproductive outcomes in women with endometriosis-associated infertility (PMID: 34585638; PMID: 29274003).

Response: The reviewer is right: these data from the literature are important and relevant to our topic. We have added a paragraph to the discussion integrating the literature suggestions of both reviewers:

Our study focuses on infertile women who have undergone IVF and achieved pregnancy. Some data in the literature have already established that endometriosis and endometriosis-induced infertility have a negative impact on quality of life [17,18]. The qualitative data we present allow us to explore the changes that take place precisely when infertility treatments have worked, and patients are pregnant. Our results are indeed in favor of an improvement during the pregnancy following IVF but suggest that this improvement is only temporary. Only quantitative data based on questionnaires should clarify whether quality of life is durably improved after pregnancy, but our results do not seem to suggest this. The interviews deliberately address very little about surgical treatment, even though most of our patients had undergone surgery prior to IVF according to an integrated approach already described in the literature [19,20]. It is likely that this integrated approach for endometriosis-associated infertility has an impact that should be explored to determine which of surgery or IVF has the greatest influence on patient experience. Several of our results also showed how these changes in patients' experiences make it difficult to resume hormone treatment after pregnancy. Several data in the literature suggest that this treatment is important to reduce the symptoms and progression of endometriosis [5,21]. Our study highlights the need to better inform patients of the importance of this medical treatment after childbirth even in the absence of symptoms.

17. Ban Frangež H, Vrtacnik Bokal E, Štimpfel M, Divjak Budihna T, Gulino FA, Garzon S, et al. Reproductive outcomes after laparoscopic surgery in infertile women affected by ovarian endometriomas, with or without in vitro fertilisation: results from the SAFE (surgery and ART for endometriomas) trial. J Obstet Gynaecol. 2022;42: 1293–1300. doi:10.1080/01443615.2021.1959536

18. Šalamun V, Verdenik I, Laganà AS, Vrtačnik-Bokal E. Should we consider integrated approach for endometriosis-associated infertility as gold standard management? Rationale and results from a large cohort analysis. Arch Gynecol Obstet. 2018;297: 613–621. doi:10.1007/s00404-017-4633-0

- Authors should discuss the detrimental role of infertility associated with endometriosis on psychological wellbeing (they may refer to: PMID: 27750472; PMID: 26319653).

Response: The reviewer is right: these data from the literature are important and relevant to our topic. We have added a paragraph to the discussion integrating the literature suggestions of both reviewers:

Our study focuses on infertile women who have undergone IVF and achieved pregnancy. Some data in the literature have already established that endometriosis and endometriosis-induced infertility have a negative impact on quality of life [17,18]. The qualitative data we present allow us to explore the changes that take place precisely when infertility treatments have worked, and patients are pregnant. Our results are indeed in favor of an improvement during the pregnancy following IVF but suggest that this improvement is only temporary. Only quantitative data based on questionnaires should clarify whether quality of life is durably improved after pregnancy, but our results do not seem to suggest this. The interviews deliberately address very little about surgical treatment, even though most of our patients had undergone surgery prior to IVF according to an integrated approach already described in the literature [19,20]. It is likely that this integrated approach for endometriosis-associated infertility has an impact that should be explored to determine which of surgery or IVF has the greatest influence on patient experience. Several of our results also showed how these changes in patients' experiences make it difficult to resume hormone treatment after pregnancy. Several data in the literature suggest that this treatment is important to reduce the symptoms and progression of endometriosis [5,21]. Our study highlights the need to better inform patients of the importance of this medical treatment after childbirth even in the absence of symptoms.

19. Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS. Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynaecol. 2017;38: 317–319. doi:10.1080/0167482X.2016.1244185

20. Laganà AS, Condemi I, Retto G, Muscatello MRA, Bruno A, Zoccali RA, et al. Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2015;194: 30–33. doi:10.1016/j.ejogrb.2015.08.015

Reviewer #2: thank you to give me the chance to review this qualitative study on the illusion of recovery during pregnancy involving patients affected by endometriosis. The study is well conducted and explored a very important topic giving new insights to medical literature. It can help counselling patients in our outpatient clinics.

Response: We thank reviewer #2 for his/her remarks.

I suggest only to revise english language throughout the manuscript and add relevant and specific literature regarding the medical therapy adopted to treat deep lesions (doi 10.1016/j.jmig.2011.04.008) focusing on the importance to suggest medical therapy also after delivery.

Response: The reviewer is right, there was a need to review the English. We did a full proofreading and editing throughout the manuscript to improve the style and syntax. We also commissioned scribbr to validate this proofreading (https://www.scribbr.fr/). We enclose the invoice as an additional document as proof. We hope the result will be satisfactory. Nevertheless, we know that these proofreading companies are not foolproof. If the reviewer finds any errors that have escaped our attention, we will gladly correct them.

The reviewer is right: these data from the literature are important and relevant to our topic. We have added a paragraph to the discussion integrating the literature suggestions of both reviewers:

Our study focuses on infertile women who have undergone IVF and achieved pregnancy. Some data in the literature have already established that endometriosis and endometriosis-induced infertility have a negative impact on quality of life [17,18]. The qualitative data we present allow us to explore the changes that take place precisely when infertility treatments have worked, and patients are pregnant. Our results are indeed in favor of an improvement during the pregnancy following IVF but suggest that this improvement is only temporary. Only quantitative data based on questionnaires should clarify whether quality of life is durably improved after pregnancy, but our results do not seem to suggest this. The interviews deliberately address very little about surgical treatment, even though most of our patients had undergone surgery prior to IVF according to an integrated approach already described in the literature [19,20]. It is likely that this integrated approach for endometriosis-associated infertility has an impact that should be explored to determine which of surgery or IVF has the greatest influence on patient experience. Several of our results also showed how these changes in patients' experiences make it difficult to resume hormone treatment after pregnancy. Several data in the literature suggest that this treatment is important to reduce the symptoms and progression of endometriosis [5,21]. Our study highlights the need to better inform patients of the importance of this medical treatment after childbirth even in the absence of symptoms.

21. Mabrouk M, Frascà C, Geraci E, Montanari G, Ferrini G, Raimondo D, et al. Combined oral contraceptive therapy in women with posterior deep infiltrating endometriosis. J Minim Invasive Gynecol. 2011;18: 470–474. doi:10.1016/j.jmig.2011.04.008

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Diego Raimondo

21 Oct 2022

Endometriosis and pregnancy: the illusion of recovery.

PONE-D-22-21031R1

Dear Dr. Netter,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Diego Raimondo

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Diego Raimondo

25 Oct 2022

PONE-D-22-21031R1

Endometriosis and pregnancy: the illusion of recovery.

Dear Dr. Netter:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Diego Raimondo

Academic Editor

PLOS ONE


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES